RLC Labs WP Thyroid, Westhroid Pure, 1.75 Grain (113.75 mg) Thyroid USP recall — FDA D-1612-2020
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Browse U.S. drug recall enforcement reports from the FDA in a structured, searchable format. Review the recalled product, reason, firm, status, dates, distribution information and FDA classification when available.
10,685 detailed records are currently available in this category.
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Subpotent Drug: FDA analysis found product to be subpotent
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Subpotent Drug: FDA analysis found product to be subpotent
Subpotent Drug: FDA analysis found product to be subpotent
CGMP Deviations: Other products were recalled because they were manufactured in the same facility as the product found to contain methanol.
CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.
CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.
Labeling Not Elsewhere Classified: Product labeled to contain methanol
Sub-Potent Drug: Out of specification test results for potency (below specification).
CGMP Deviations: Products manufactured at the same site were FDA testing found below the label claim for ethanol content and the presence of undeclared methanol.
Marketed without an Approved NDA/ANDA; product labeled to contain 0.56% methanol making it an unapproved new drug
cGMP deviations
Chemical Contamination: Product contains methanol.
Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection,…
Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection,…
CGMP Deviation: Potential contamination with undeclared methanol.
CGMP Deviations
Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain…
Cross Contamination with other products: trace amounts of lidocaine
Superpotent Drug: Active Ingredient Octisalate found at 15% above label claim.
Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain…
Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain…
A drug recall record can include the reason for recall, firm, status, distribution pattern, quantity and FDA classification. This site does not provide medical advice; it organizes public recall information and links users back to official sources.
Recall Lookup USA keeps the last complete source record available when an official data service is temporarily unavailable. When a source provides only a few fields, we show only those known facts rather than padding the page with generic text.
This database is designed for discovery and reference. It can help you locate a relevant recall record, identify the recalling firm or NHTSA campaign, compare dates and classifications, and follow the official source. It is not a substitute for a VIN-specific NHTSA check, a manufacturer notice, medical advice or instructions issued by the recalling company.